HYDERABAD, India--(BUSINESS WIRE)--Platrol® has demonstrated 40% more efficacy and negligible toxicity resulting in higher therapeutic index compared to Aspirin, Clopidogrel and other anti-platelet drugs in clinical trials. Surprisingly, its inherent sustained release property makes Platrol® even better as a long-term cardio-protective drug.
